Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients
NCT03909399 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-02-10
Summary
Prevention and Prophylaxis (Thromboprophylaxis - ACT) of Cancer Associated Thrombosis (CAT) in High Risk Oncology Patients: ACT4CAT.
Conditions
- Deep Vein Thrombosis
- Pulmonary Embolism
- Vena Cava Thrombosis
- Iliac; Thrombosis
Sponsors & Collaborators
-
Hellenic Society of Medical Oncology
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-25
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- Greece
Study Locations
More Related Trials
-
Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
NCT06714734 ·Status: RECRUITING
-
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
NCT04846556 ·Status: COMPLETED
-
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
NCT07215624 ·Status: RECRUITING
-
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
NCT02898051 ·Status: UNKNOWN
-
Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study
NCT05229471 ·Status: UNKNOWN
-
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
NCT02744092 ·Status: COMPLETED ·Phase: NA
-
Study on Thrombosis Therapy in German Cancer Patients
NCT01559883 ·Status: COMPLETED
-
DOAC - Dosing Options in AntiCoagulation Prophylaxis
NCT07005024 ·Status: RECRUITING ·Phase: PHASE3
-
Allo - Cancer - Thrombosis
NCT03563924 ·Status: UNKNOWN
-
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
NCT01164046 ·Status: TERMINATED ·Phase: PHASE3
-
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
NCT05240508 ·Status: UNKNOWN
-
Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism
NCT02017743 ·Status: UNKNOWN
-
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
NCT01999179 ·Status: COMPLETED ·Phase: NA
-
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
NCT00951574 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
NCT01803022 ·Status: COMPLETED
-
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
NCT00375076 ·Status: COMPLETED ·Phase: PHASE3
-
Catheter Directed Interventions in Pulmonary Embolism
NCT03595085 ·Status: UNKNOWN ·Phase: NA
-
A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient
NCT03114618 ·Status: COMPLETED
-
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
NCT03407469 ·Status: RECRUITING
-
Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
NCT01602445 ·Status: COMPLETED
-
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
NCT03781531 ·Status: RECRUITING
-
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
NCT00024297 ·Status: COMPLETED ·Phase: NA
-
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
NCT03045406 ·Status: COMPLETED ·Phase: PHASE3
-
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
NCT04479579 ·Status: COMPLETED ·Phase: PHASE4
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING